Changes in Neuropsychiatric Symptoms after Switching from Elexacaftor/Tezacaftor/Ivacaftor to Vanzacaftor/Tezacaftor/Deutivacaftor: A Single-Center Experience
Respir Med. 2026 Nov 6:109268. doi: 10.1016/j.rmed.2026.109268. Online ahead of print.ABSTRACTBACKGROUND: Neuropsychiatric adverse effects (AEs) have increasingly been reported with elexacaftor/tezacaftor/ivacaftor (ETI) in people with...
